We are pleased to share an important milestone in our commitment to diagnostic excellence. Following our participation in the 2026 NordiQC assessment (Participant 1697), our core immunohistochemistry (IHC) products have demonstrated strong performance. Proven Quality The results show that our reagents give consistent, reliable, and repeatable staining. We are proud to have earned "Optimal" scores for two critical markers: HER2: Essential for guiding targeted breast cancer treatments. MSH2:A key marker for identifying Lynch syndrome and screening for immunotherapy. Additionally, important indicators such as PAX5, MLH1, CDX2, CALRET, and MUM1 got "Good" ratings, proving they work well across breast, GI, and other tumors. Why NordiQC Matters NordiQC is an ISO 17043-accredited proficiency testing program, recognized as the world's most rigorous external quality assessment scheme for diagnostic IHC.Their assessments are designed to ensure that laboratories worldwide can trust their diagnostic results. Advancing Laboratory Performance This launch represents more than a quality score—it reflects our commitment to the reliability your laboratory depends on. Whether supporting Lynch syndrome screening or guiding breast cancer therapy selection, our NordiQC-validated reagents deliver consistent, trustworthy staining results across every slide. Click www.talentdiagnostics.com to explore our full portfolio of assessed antibodies and enhance your laboratory's diagnostic precision.

We are pleased to introduce our dual staining products–powerful tools designed to help pathologists confidently distinguish benign prostate conditions from prostate cancer. The Challenge Telling benign prostatic hyperplasia from prostate cancer is a common diagnostic challenge. H&E staining alone often makes it difficult to tell them apart. Additionally, relying on a single antibody marker is not always reliable. Our Solution Our Primary antibody combines two or three key markers on a single slide: AMACR (P504S) – Overexpressed in prostate cancer cells p63 – Marks basal cells, which are lost in cancer CKHMW（CK(34βE12) ） – Another basal cell marker, also lost in cancer How It Works Normal prostate glands have two cell layers – basal cells and epithelial cells. In benign prostate tissue, the basal cell layer is complete and the glandular cells appear normal.In prostate cancer, however, basal cells are almost gone and glandular cells have turned abnormal. So we use AMACR (P504S) to check for cancerous glandular cells, and p63/CKHMW – both in the same color – to see whether basal cells are present or not. Key Benefits Color-coded for easy reading – See at a glance whether basal cells are present Reduces misdiagnosis – Helps avoid confusing benign hyperplasia with cancer Enables early intervention – Identifies precancerous changes before they progress Saves tissue – Three markers on one slide means less sample needed Two color choices – You can choose between two staining modes to match your needs when using our detection kit Flexible use – Compatible with manual and automated staining All products come with full regulatory registration. Talent Biomedical delivers accurate, reliable solutions for prostate cancer diagnosis. CK(34βE12)/P504S + Universal Dual Stain Kit (Anti-Mouse AP/Anti-Rabbit HRP) – staining results. AMACR/p63/CKHMW +Universal Dual Stain Kit(Anti-Mouse HRP/Anti-Rabbit AP)– staining results.

We are excited to introduce our p16/Ki-67 Dual Stain Kit -a complete, ready-to-use solution for cervical tissue biopsies. 1.The Challenge Diagnosing cervical intraepithelial neoplasia (CIN) from tissue biopsies can be difficult. Morphological assessment alone often leads to uncertainty, especially when distinguishing CIN1 from CIN2/3. This can result in misdiagnosis, delayed treatment, or unnecessary procedures. 2.Our Solution The p16/Ki-67 Dual Stain Kit detects two key biomarkers -- p16 (a marker of cell cycle disruption) and Ki-67 (a marker of cell proliferation) -- on a single slide. Co-expression of both markers in the same cells strongly indicates high-grade lesions (CIN2+), providing objective molecular evidence to support pathological diagnosis.. 3.Key Benefits Improves diagnostic accuracy – Dual staining offers significantly higher sensitivity and specificity compared to p16 or Ki-67 alone Aids in CIN grading – Helps pathologists confidently distinguish low-grade from high-grade lesions Reduces diagnostic variability – Provides objective, color-coded results that improve inter-observer agreement All-in-one convenience – Complete kit with matched antibodies and reagents; compatible with manual and automated protocols With the p16/Ki-67 Dual Stain Kit, Talent Bio helps pathologists make more accurate and confident diagnoses from cervical tissue biopsies –supporting better patient care and treatment decisions. p16/Ki-67 Tissuse Staining p16/Ki-67 Dual Staining Kit